Diann E Gaalema1, Mollie E Miller2, Jennifer W Tidey2. 1. Vermont Center of Behavior and Health, University of Vermont, Burlington VT. 2. Center for Alcohol and Addictions Studies, Brown University, Providence RI.
Abstract
OBJECTIVES: In 2009 the FDA acquired the authority to reduce the nicotine content in cigarettes if appropriate for public health, prompting research to evaluate the implications of this policy scientifically. Studies in non-psychiatric populations show that reducing the nicotine content of cigarettes to non-addictive levels reduces smoking rates and nicotine dependence. However, few studies have examined this hypothesis in vulnerable populations. METHODS: In this narrative review we examined the extant literature on the effects of nicotine reduction or cessation on symptoms of withdrawal, as well as psychiatric symptoms, among those with affective disorders. RESULTS: Following initial withdrawal from nicotine, smokers with affective disorders experience more severe mood disruption than smokers without these disorders. Use of very low nicotine content (VLNC) cigarettes during abstinence may help mitigate the mood-disrupting effects of initial abstinence. Once the initial effects of nicotine withdrawal on mood have passed, longer-term abstinence is associated with psychiatric improvement rather than worsening. CONCLUSIONS: These findings suggest that if a national nicotine reduction policy were to be implemented, smokers with affective disorders would need additional support to overcome initial withdrawal but that long-term outcomes would likely be positive.
OBJECTIVES: In 2009 the FDA acquired the authority to reduce the nicotine content in cigarettes if appropriate for public health, prompting research to evaluate the implications of this policy scientifically. Studies in non-psychiatric populations show that reducing the nicotine content of cigarettes to non-addictive levels reduces smoking rates and nicotine dependence. However, few studies have examined this hypothesis in vulnerable populations. METHODS: In this narrative review we examined the extant literature on the effects of nicotine reduction or cessation on symptoms of withdrawal, as well as psychiatric symptoms, among those with affective disorders. RESULTS: Following initial withdrawal from nicotine, smokers with affective disorders experience more severe mood disruption than smokers without these disorders. Use of very low nicotine content (VLNC) cigarettes during abstinence may help mitigate the mood-disrupting effects of initial abstinence. Once the initial effects of nicotine withdrawal on mood have passed, longer-term abstinence is associated with psychiatric improvement rather than worsening. CONCLUSIONS: These findings suggest that if a national nicotine reduction policy were to be implemented, smokers with affective disorders would need additional support to overcome initial withdrawal but that long-term outcomes would likely be positive.
Authors: Ovide F Pomerleau; Cynthia S Pomerleau; Ann M Mehringer; Sandy M Snedecor; Raphaela Ninowski; Ananda Sen Journal: Nicotine Tob Res Date: 2005-02 Impact factor: 4.244
Authors: Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori Journal: JAMA Date: 2010-12-08 Impact factor: 56.272
Authors: Robert M Anthenelli; Chad Morris; Tanya S Ramey; Sarah J Dubrava; Kostas Tsilkos; Cristina Russ; Carla Yunis Journal: Ann Intern Med Date: 2013-09-17 Impact factor: 25.391
Authors: Jason D Robinson; George Kypriotakis; Mustafa Al'absi; Rachel L Denlinger-Apte; David J Drobes; Scott J Leischow; F Joseph McClernon; Lauren R Pacek; Herbert H Severson; Tracy T Smith; Eric C Donny; Xianghua Luo; Joni A Jensen; Lori G Strayer; Paul M Cinciripini; Dorothy K Hatsukami Journal: Nicotine Tob Res Date: 2020-07-16 Impact factor: 4.244
Authors: Tracy T Smith; Laura E Rupprecht; Rachel L Denlinger-Apte; Jillian J Weeks; Rachel S Panas; Eric C Donny; Alan F Sved Journal: Nicotine Tob Res Date: 2017-09-01 Impact factor: 4.244
Authors: Jennifer W Tidey; Lauren R Pacek; Joseph S Koopmeiners; Ryan Vandrey; Natalie Nardone; David J Drobes; Neal L Benowitz; Sarah S Dermody; Andrine Lemieux; Rachel L Denlinger; Rachel Cassidy; Mustafa al'Absi; Dorothy K Hatsukami; Eric C Donny Journal: Nicotine Tob Res Date: 2016-08-03 Impact factor: 4.244
Authors: Jennifer W Tidey; Danielle R Davis; Mollie E Miller; Irene Pericot-Valverde; Rachel L Denlinger-Apte; Diann E Gaalema Journal: Prev Med Date: 2018-07-03 Impact factor: 4.018
Authors: Jason D Robinson; George Kypriotakis; Maher Karam-Hage; Charles E Green; Dorothy K Hatsukami; Paul M Cinciripini; Eric C Donny Journal: Nicotine Tob Res Date: 2017-09-01 Impact factor: 4.244
Authors: Diann E Gaalema; Jennifer W Tidey; Danielle R Davis; Stacey C Sigmon; Sarah H Heil; Maxine L Stitzer; Michael J Desarno; Valeria Diaz; John R Hughes; Stephen T Higgins Journal: Nicotine Tob Res Date: 2019-12-23 Impact factor: 4.244